New Article information at Pharmaceutical Technology New and updated information from Article listed on www.pharmaceutical-technology.com http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ New Article information at Pharmaceutical Technology http://www.pharmaceutical-technology.com/content/images/logo_big.gif BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial http://www.pharmaceutical-technology.com/features/featurecanadas-stem-cell-contender-5819576/ http://www.pharmaceutical-technology.com/features/featurecanadas-stem-cell-contender-5819576/ Toronto-based regenerative medicine biotech BlueRock Therapeutics was launched in December with a massive $225m series A financing. So what stem cell-based therapies is the company working on? Sun, 21 May 2017 23:00:00 GMT European Molecular Biology Laboratory Site, Barcelona http://www.pharmaceutical-technology.com/projects/european-molecular-biology-laboratory-site-barcelona/ http://www.pharmaceutical-technology.com/projects/european-molecular-biology-laboratory-site-barcelona/ European Molecular Biology Laboratory (EMBL) is developing a new facility within the Barcelona Biomedical Research Park (PRBB) campus in Spain. Thu, 18 May 2017 23:00:00 GMT Micro-machines: nanotech offers new possibilities for disease detection and drug delivery http://www.pharmaceutical-technology.com/features/featuremicro-machines-nanotech-offers-new-possibilities-for-disease-detection-and-drug-delivery-5810319/ http://www.pharmaceutical-technology.com/features/featuremicro-machines-nanotech-offers-new-possibilities-for-disease-detection-and-drug-delivery-5810319/ For the first time, miniscule molecular machines designed for early disease detection and targeted drug delivery have been shown to work in living cells. Elly Earls meets the researchers behind the breakthrough to find out more. Wed, 17 May 2017 23:00:00 GMT Pharma Technology Focus – Issue 59 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-59-5816891/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-59-5816891/ In this issue: Challenging the link between innovation and US drug pricing, the impact of Brexit on life sciences companies, a new study on the effects of cognitive-enhancing drugs, using crowdfunding to unlock cancer therapies, and more. Wed, 17 May 2017 13:58:00 GMT Challenging the link between pharma innovation and US drug pricing http://www.pharmaceutical-technology.com/features/featurechallenging-the-link-between-pharma-innovation-and-us-drug-pricing-5813154/ http://www.pharmaceutical-technology.com/features/featurechallenging-the-link-between-pharma-innovation-and-us-drug-pricing-5813154/ A new study claims to debunk the well-worn connection between inflated US drug prices and big pharma’s R&D spending. But what is the connection between innovation and pricing in the pharma space, and is it the whole story? Fri, 12 May 2017 16:12:00 GMT Brain boosters: exploring the grey area of off-label ‘smart drugs’ http://www.pharmaceutical-technology.com/features/featurebrain-boosters-exploring-the-grey-area-of-off-label-smart-drugs-5813135/ http://www.pharmaceutical-technology.com/features/featurebrain-boosters-exploring-the-grey-area-of-off-label-smart-drugs-5813135/ The growing trend for the unlicensed use of cognitive-enhancing drugs to improve performance is prompting calls for more research into the field. Has the era of brain-boosting ‘smart pills’ arrived, and what do we still need to find out about the saf… Fri, 12 May 2017 15:22:00 GMT AstraZeneca R&D Centre and Corporate Headquarters, Cambridge http://www.pharmaceutical-technology.com/projects/astra-zeneca-cambridge/ http://www.pharmaceutical-technology.com/projects/astra-zeneca-cambridge/ UK-Swedish pharmaceutical and biologics company AstraZeneca is building a new global R&D centre and corporate headquarters on the Cambridge Biomedical Campus (CBC) in Cambridge, UK. Thu, 11 May 2017 23:00:00 GMT Medical Sciences Building (MSB) II, Texas Tech University Health Sciences Center El Paso http://www.pharmaceutical-technology.com/projects/medical-sciences-building-msb-ii-texas-tech-university-health-sciences-center-el-paso/ http://www.pharmaceutical-technology.com/projects/medical-sciences-building-msb-ii-texas-tech-university-health-sciences-center-el-paso/ Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) will soon feature a new medical sciences building at its campus in Texas, US. Wed, 10 May 2017 23:00:00 GMT UTEP Interdisciplinary Research Building (IDRB), Texas http://www.pharmaceutical-technology.com/projects/utep-interdisciplinary-research-building-idrb-texas/ http://www.pharmaceutical-technology.com/projects/utep-interdisciplinary-research-building-idrb-texas/ The University of Texas at El Paso (UTEP) has initiated construction of an interdisciplinary research building (IDRB) at 500 West University Avenue in Texas, US. Sun, 07 May 2017 23:00:00 GMT Crowdfunding for cancer therapy http://www.pharmaceutical-technology.com/features/featurecrowdfunding-for-cancer-therapy-5806072/ http://www.pharmaceutical-technology.com/features/featurecrowdfunding-for-cancer-therapy-5806072/ The Care Oncology Clinic is crowdfunding to help provide patients access to four repurposed drugs, alongside conventional NHS cancer drug treatment therapy. Why is there a need for such a funding mechanism, and what evidence do they have to support t… Sun, 07 May 2017 23:00:00 GMT Biosciences Partnership Building, Phoenix http://www.pharmaceutical-technology.com/projects/biosciences-partnership-building-phoenix/ http://www.pharmaceutical-technology.com/projects/biosciences-partnership-building-phoenix/ The University of Arizona (UA) College of Medicine in Phoenix, Arizona, US, broke ground on a new research facility named Biosciences Partnership Building on the Phoenix Biomedical Campus, a major bioresearch and education hub in downtown Phoenix in … Thu, 04 May 2017 23:00:00 GMT April's top stories: CN Bio licenced Hepatitis B drug programme, Astellas agreed to acquire Ogeda for €800m http://www.pharmaceutical-technology.com/features/featureaprils-top-stories-cn-bio-licences-hepatitis-b-drug-astellas-to-acquire-ogeda-for-800m-5800044/ http://www.pharmaceutical-technology.com/features/featureaprils-top-stories-cn-bio-licences-hepatitis-b-drug-astellas-to-acquire-ogeda-for-800m-5800044/ CN Bio licenced a Hepatitis B drug discovery programme from Bristol-Myers Squibb and Astellas Pharma agreed to acquire Belgium’s Ogeda for €800m. Pharmaceutical-technology.com wraps up the key headlines from April. Mon, 01 May 2017 23:00:00 GMT Sinergium Biotech Antigen Production Plant, Buenos Aires http://www.pharmaceutical-technology.com/projects/sinergium-biotech-antigen-production-plant-buenos-aires/ http://www.pharmaceutical-technology.com/projects/sinergium-biotech-antigen-production-plant-buenos-aires/ Sinergium Biotech has announced it will begin construction of a new primary antigen production plant in the town of Garin, which is located in the province of Buenos Aires, Argentina. Thu, 27 Apr 2017 23:00:00 GMT Rosalind Franklin Biotechnology Center, Delft http://www.pharmaceutical-technology.com/projects/rosalind-franklin-biotechnology-center-delft/ http://www.pharmaceutical-technology.com/projects/rosalind-franklin-biotechnology-center-delft/ Royal DSM has opened new facility the Rosalind Franklin Biotechnology Centre at the Delt campus, theNetherlands. Wed, 26 Apr 2017 23:00:00 GMT The London Cancer Hub, Sutton http://www.pharmaceutical-technology.com/projects/the-london-cancer-hub-sutton/ http://www.pharmaceutical-technology.com/projects/the-london-cancer-hub-sutton/ The London Cancer Hub for Cancer Research and Treatment in Sutton, London, will be developed by the Institute of Cancer Research (ICR), London, and the London Borough of Sutton in collaboration with The Royal Marsden NHS Foundation Trust, the Greater… Thu, 20 Apr 2017 23:00:00 GMT Narrowing the hunt for nanoparticles http://www.pharmaceutical-technology.com/features/featurenarrowing-the-hunt-for-nanoparticles-5776258/ http://www.pharmaceutical-technology.com/features/featurenarrowing-the-hunt-for-nanoparticles-5776258/ Researchers from the Universities of Geneva and Fribourg have devised a rapid screening method to select the most promising nanoparticles for drug development. Lead author Inès Mottas tells Abi Millar how better access to the nanosphere could improve… Wed, 19 Apr 2017 23:00:00 GMT Pharma Technology Focus – Issue 58 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-58-5791122/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-58-5791122/ In this issue: Promising Alzheimer’s drugs in development, potential applications for the hormone kisspeptin, the cost of failed drug candidates, a new app matching patients to clinical trials, pharma packaging trends, and more. Wed, 19 Apr 2017 13:56:00 GMT Medical and Research Translation (MART) Building, Stony Brook University http://www.pharmaceutical-technology.com/projects/medical-and-research-translation-mart-building-stony-brook-university/ http://www.pharmaceutical-technology.com/projects/medical-and-research-translation-mart-building-stony-brook-university/ The construction of the Medical and Research Translation (MART) building at the Stony Brook University (SBU) medical centre campus began in November 2013. Wed, 12 Apr 2017 23:00:00 GMT Pharmaceutical packaging: where should drug companies focus their efforts? http://www.pharmaceutical-technology.com/features/featurepharmaceutical-packaging-where-should-drug-companies-focus-their-efforts-5775849/ http://www.pharmaceutical-technology.com/features/featurepharmaceutical-packaging-where-should-drug-companies-focus-their-efforts-5775849/ The future of pharmaceutical packaging operations is far from straightforward. The Association for Packaging and Processing Technologies reveals where drug companies should be focusing their efforts. Sun, 09 Apr 2017 23:00:00 GMT Michael Uren Biomedical Engineering Research Hub, London http://www.pharmaceutical-technology.com/projects/michael-uren-biomedical-engineering/ http://www.pharmaceutical-technology.com/projects/michael-uren-biomedical-engineering/ Michael Uren Biomedical Engineering Research Hub is a state-of-the-art laboratory and office facility being developed at Imperial College London’s campus in White City, London, UK. Sun, 09 Apr 2017 23:00:00 GMT